ACIU
Income statement / Annual
Last year (2023), AC Immune SA's total revenue was $14.80 M,
an increase of 276.14% from the previous year.
In 2023, AC Immune SA's net income was -$54.23 M.
See AC Immune SA’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$14.80 M
|
$3.94 M
|
$0.00
|
$15.43 M
|
$111.03 M
|
$7.19 M
|
$20.26 M
|
$23.21 M
|
$39.09 M
|
$30.27 M
|
| Cost of Revenue |
$54.61 M |
$60.34 M |
$62.28 M |
$59.49 M |
$50.43 M |
$44.28 M |
$32.66 M |
$25.77 M |
$17.05 M |
$16.12 M |
| Gross Profit |
-$39.81 M |
-$56.40 M |
-$62.28 M |
-$44.06 M |
$60.59 M |
-$37.08 M |
-$12.41 M |
-$2.56 M |
$22.04 M |
$14.15 M |
| Gross Profit Ratio |
-2.69 |
-14.33 |
0 |
-2.86 |
0.55 |
-5.15 |
-0.61 |
-0.11 |
0.56 |
0.47 |
| Research and Development
Expenses |
$54.61 M
|
$60.34 M
|
$62.28 M
|
$59.49 M
|
$50.43 M
|
$44.28 M
|
$32.66 M
|
$25.77 M
|
$17.05 M
|
$16.12 M
|
| General & Administrative
Expenses |
$10.58 M
|
$15.79 M
|
$10.88 M
|
$11.09 M
|
$9.42 M
|
$7.56 M
|
$6.27 M
|
$4.73 M
|
$2.04 M
|
$2.00 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$10.58 M
|
$15.79 M
|
$10.88 M
|
$11.09 M
|
$9.42 M
|
$7.56 M
|
$6.27 M
|
$4.73 M
|
$2.04 M
|
$2.00 M
|
| Other Expenses |
-$51.36 M |
-$1.34 M |
$5.85 M |
$6.12 M |
$6.64 M |
$4.90 M |
$3.86 M |
$3.17 M |
$1.38 M |
$1.44 M |
| Operating Expenses |
$13.82 M |
$74.78 M |
$79.01 M |
$76.69 M |
$66.49 M |
$56.74 M |
$42.79 M |
$33.67 M |
$20.47 M |
$19.55 M |
| Cost And Expenses |
$68.43 M |
$74.78 M |
$79.01 M |
$76.69 M |
$66.49 M |
$56.74 M |
$42.79 M |
$33.67 M |
$20.47 M |
$19.55 M |
| Interest Income |
$1.04 M |
$69,000.00 |
$6.49 M |
$78,000.00 |
$304,000.00 |
$29,000.00 |
$330,000.00 |
$43,000.00 |
$55,000.00 |
$22,000.00 |
| Interest Expense |
$176,000.00 |
$355,000.00 |
$581,000.00 |
$184,000.00 |
$1.89 M |
$298,000.00 |
$147,000.00 |
$256,000.00 |
$26,000.00 |
$4,000.00 |
| Depreciation &
Amortization |
$2.22 M
|
$2.36 M
|
$1.90 M
|
$1.97 M
|
$1.69 M
|
$961,000.00
|
$580,000.00
|
$278,000.00
|
$287,000.00
|
$298,000.00
|
| EBITDA |
-$51.83 M
|
-$69.05 M
|
-$77.11 M
|
-$61.26 M
|
$44.54 M
|
-$49.66 M
|
-$22.54 M
|
-$6.81 M
|
$18.91 M
|
$11.02 M
|
| EBITDA Ratio |
-3.5 |
-17.99 |
0 |
-3.84 |
0.42 |
-6.74 |
-1.07 |
-0.28 |
0.53 |
0.36 |
| Operating Income Ratio
|
-3.62
|
-18
|
0
|
-3.97
|
0.4
|
-6.89
|
-1.11
|
-0.45
|
0.48
|
0.35
|
| Total Other
Income/Expenses Net |
-$599,000.00
|
$107,000.00
|
$6.02 M
|
-$661,000.00
|
$906,000.00
|
-$1.40 M
|
-$3.87 M
|
$3.36 M
|
$1.65 M
|
$27,000.00
|
| Income Before Tax |
-$54.22 M |
-$70.74 M |
-$72.99 M |
-$61.92 M |
$45.44 M |
-$50.95 M |
-$26.41 M |
-$7.10 M |
$20.27 M |
$10.74 M |
| Income Before Tax Ratio
|
-3.66
|
-17.98
|
0
|
-4.01
|
0.41
|
-7.08
|
-1.3
|
-0.31
|
0.52
|
0.35
|
| Income Tax Expense |
$10,000.00 |
$13,000.00 |
$3,000.00 |
$184,000.00 |
$1.89 M |
-$1.10 M |
$147,000.00 |
$3.62 M |
$1.64 M |
$31,000.00 |
| Net Income |
-$54.23 M |
-$70.75 M |
-$73.00 M |
-$62.11 M |
$45.44 M |
-$50.95 M |
-$26.41 M |
-$7.10 M |
$20.27 M |
$10.74 M |
| Net Income Ratio |
-3.66 |
-17.98 |
0 |
-4.02 |
0.41 |
-7.08 |
-1.3 |
-0.31 |
0.52 |
0.35 |
| EPS |
-0.64 |
-0.85 |
-0.97 |
-0.86 |
0.64 |
-0.82 |
-0.46 |
-0.14 |
0.37 |
0.19 |
| EPS Diluted |
-0.64 |
-0.85 |
-0.97 |
-0.86 |
0.64 |
-0.82 |
-0.46 |
-0.14 |
0.37 |
0.19 |
| Weighted Average Shares
Out |
$84.69 M
|
$83.55 M
|
$74.95 M
|
$71.90 M
|
$70.60 M
|
$61.84 M
|
$57.08 M
|
$50.10 M
|
$55.40 M
|
$55.40 M
|
| Weighted Average Shares
Out Diluted |
$84.69 M
|
$83.55 M
|
$74.95 M
|
$71.90 M
|
$71.10 M
|
$61.84 M
|
$57.36 M
|
$50.10 M
|
$55.40 M
|
$55.40 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
